I just want to be

IC/BPS is a condition recognized by the American Urologic Association that manifests as unpleasant symptoms such as pain, discomfort, and urinary pressure centered on the bladder.

Diagnosis is challenging as the condition lacks a tell-tale biomarker or test that provides a definitive answer. Therefore, diagnosis is generally symptom-based. IC/BPS often shares common characteristics with urinary tract infections (UTIs) but exists in the absence of infection or other identifiable causes. Symptoms typically last for more than 6 weeks

GainME-IC is a clinical study investigating use of lidocaine in a disease-targeted formulation, aiming to potentially develop an investigational medicine that might support relief for individuals living with IC. This study is designed to assess the safety and tolerability of an intravesical (into the bladder) administration of an investigational lidocaine medication in female patients with IC/BPS.

Since most cases occur in women, this portion of the study will focus on women 18-64 years old who have a diagnosis of, or symptoms consistent with, IC/BPS.

If you have a diagnosis of IC/BPS or symptoms consistent with the condition, you know there are significant quality-of-life disruptions. So, at its heart, the GainME-IC study is about developing a medicine to address these symptoms and advancing medical science toward possible treatments.